article thumbnail

The Current State of Animal Testing in Beauty - Blog Version

The Eco Well Blog

This is especially untrue now with the 2021 animal testing ammendments. The dark history of Cosmetics Safety From the 18th century’s use of lead carbonate in makeup to the use of radium in the 1920s and 30s, there have been many deaths in the name of beauty. Historically animals have been used as an indicator of safety.

Safety 52
article thumbnail

New Sunscreen Ingredients: Unmet Needs and Key Considerations

The Dermatology Digest

New sunscreen ingredients are needed to help assuage patient safety concerns and lower skin cancer rates. Bis (diethylamino hydroxybenzoyl benzoyl) piperazine (BDBP) was approved by the Scientific Committee on Consumer Safety (SCCS) of the European Commission in 2021 and is being considered in the US.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A comment on the 2024 EWG Sunscreen Guide; Is EWG actively harming safe consumer sun protection?

The Eco Well Blog

prevention of skin cancer, UV induced hyperpigmentation, painful sunburn, melasma, etc) far outweigh any potential risks.Sunscreens have a long track record of safety and still, despite some of the scary media reporting on the recent FDA studies, are overwhelmingly supported to be safe and effective. Does this make sense to anyone?

article thumbnail

And Then There Were Six…FDA Green Lights Hugel’s Toxin for Glabellar Lines

The Dermatology Digest

.” Coral Gables, FL-based dermatologist Joely Kaufman, MD, adds, “The results from the clinical trials for letibotulinumtoxinA demonstrate efficacy, and a convincing safety profile in the treatment of glabellar lines. Hugel filed its first Biologics License Application in 2021, which was rejected by the FDA in 2022.

article thumbnail

Using CO2 Laser + Other Modalities to Treat Skin Pigmentation

Lipgloss and Aftershave

Sequence Treatments for Safety: Estheticians can schedule less invasive treatments first and reserve higher-intensity therapies for later sessions to reduce skin sensitization. Intense Pulsed Light (IPL) While not a laser, IPL uses broad-spectrum light to treat pigmentation by targeting the chromophore melanin within the dermis. Draelos, Z.,

article thumbnail

FDA to Review Biofrontera’s sNDA for Ameluz Dosage Increase

The Dermatology Digest

The sNDA is supported by two clinical phase I studies investigating the safety of the application of three tubes of Ameluz. Further to a Type A meeting with the FDA in 2021, an additional safety trial with 100 patients receiving PDT with three tubes of Ameluz was conducted. This data also formed part of the sNDA.

Safety 28
article thumbnail

Biosimilar News: FDA Approves High-concentration, Citrate-free Formulation of Cyltezo, a Biosimilar to Humira

The Dermatology Digest

The FDA approved Cyltezo as an interchangeable biosimilar to Humira on October 15, 2021. The FDA approval is based, in part, on data from clinical trial VOLTAIRE-HCLF , a Phase I clinical trial comparing the bioavailability of high-concentration and low-concentration formulations of adalimumab-adbm.